ABK Biomedical

ABK Biomedical, founded in 2012, focuses on the research, development, and commercialization of breakthrough medical device therapies to improve treatment outcomes and quality of life for patients with benign and malignant hypervascular tumors. It is committed to leading the research, development, and manufacturing of state-of-the-art medical device technologies for the treatment of liver cancer and vascular tumors.